Nature-Cide to Highlight its Botanical Pest Control Solutions at Leading Mosquito Control Industry Event in Portland, OregonLOS ANGELES, CA / ACCESS Newswire / March 23, 2026 / Med-X, Inc. (&#34;Med-X&#34; or the &#34;Company&#34;)

<p><i><strong>Nature-Cide to Highlight its Botanical Pest Control Solutions at Leading Mosquito Control Industry Event in Portland, Oregon</strong></i></p><p><strong id="dateline">LOS ANGELES, CA / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / March 23, 2026 / </strong>Med-X, Inc. ("Med-X" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/MXRX">MXRX</a>), a leading innovator in all-natural pest control solutions, today announced that its flagship Nature-Cide&#xAE; product line will be featured at the American Mosquito Control Association's (AMCA) 92nd Annual Meeting, taking place March 23-27, 2026, at the Oregon Convention Center in Portland, Oregon. Attendees are invited to visit Nature-Cide at Booth 214 to explore the Company's full portfolio of botanical pest management solutions.</p><p>The AMCA Annual Meeting is the premier educational and networking event for researchers, vector control professionals, public health officials, and industry leaders focused on mosquito control. The conference attracts hundreds of attendees annually and features scientific presentations, technical sessions, and an expansive exhibit hall showcasing the latest innovations in vector and pest management.</p><p>Nature-Cide's participation underscores Med-X's ongoing commitment to advancing safer, environmentally responsible alternatives within the professional vector control market. Nature-Cide products are formulated with a proprietary blend of botanical essential oils-including clove, cottonseed, cedar, and cinnamon-and have demonstrated effectiveness in independent third-party studies against a broad spectrum of insect. In addition to insect control, Nature-Cide products are also designed to repel rodents, reptiles, and certain bird species, without the harmful effects associated with traditional synthetic chemical pesticides.</p><p>Matthew Mills, CEO of Med-X, Inc. stated: "Our latest formulation, Nature-Cide Pest Management X2 Plus, which is OMRI listed, is proving very effective within the pest control industry. AMCA offers us the opportunity to continue making a difference in every aspect of pest control.</p><p>"Our management team, Board of Directors, as well as our shareholders are committed to continuing forging a path around the world to bring environmentally friendly solutions where they are needed the most."</p><p><strong>About Med-X, Inc.</strong><br/>Med-X, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/MXRX">MXRX</a>) is a leading innovator of biological pest control solutions serving both consumer and professional markets worldwide. Nature-Cide&#xAE;, the Company's flagship product line, provides a safer, all-natural alternative to conventional chemical pesticides and is formulated to kill or repel a wide range of pests. Med-X's comprehensive go-to-market strategy includes strategic partnerships, as well as an integrated presence across e-commerce, retail, and on-site services in key markets. For more information, please visit <a rel="nofollow" href="https://pr.report/jzqz">www.medx-rx.com</a>.</p><p><strong>Cautionary Note Regarding Forward-Looking Statements</strong><br/>This press release contains forward-looking statements within the meaning of applicable securities laws. These statements include, but are not limited to, statements regarding plans, objectives, strategies, future events, and expected performance. Words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," and similar expressions are intended to identify forward-looking statements. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including factors such as market conditions, competitive dynamics, regulatory developments, and other risks detailed in the Company's filings with the U.S. Securities and Exchange Commission (SEC). Investors are cautioned not to place undue reliance on forward-looking statements. Additional information can be found in the Company's SEC filings at <a rel="nofollow" href="https://pr.report/jzr0">www.sec.gov</a>.</p><p><strong>Investor Relations Contact</strong><br/>Lucas A. Zimmerman & Ian Scargill<br/>MZ Group - MZ North America<br/>(949) 259-4987<br/><a rel="nofollow" href="mailto:MXRX@mzgroup.us">MXRX@mzgroup.us</a><br/><a rel="nofollow" href="https://pr.report/jzr1">www.mzgroup.us</a></p><p><strong>SOURCE:</strong> Med-X, Inc.</p><br/><br/>View the original <a href='https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/med-x-to-showcase-nature-cide-at-amcas-92nd-annual-meeting-1150547'>press release</a> on ACCESS Newswire<br/><br/>
      <img src="https://app.accessnewswire.com/img.ashx?id=1150547" width="0" height="0"/>

MEDH

Med-X to Showcase Nature-Cide at AMCA's 92nd Annual Meeting

Med-X Showcases Nature-Cide at Premier Mosquito Control Conference

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>Nature-Cide to Highlight its Botanical Pest Control Solutions at Leading Mosquito Control Industry Event in Portland, OregonLOS ANGELES, CA / ACCESS Newswire / March 23, 2026 / Med-X, Inc. (&amp;#34;Med-X&amp;#34; or the &amp;#34;Company&amp;#34;)</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Med-X, Inc. will showcase its Nature-Cide product line at the American Mosquito Control Association&#039;s Annual Meeting, emphasizing innovative pest control solutions. With a commitment to environmentally responsible alternatives, this event could bolster Med-X&#039;s market presence and lead to new partnerships.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Med-X will feature Nature-Cide at AMCA&#039;s Annual Meeting in Oregon.</li><li>Nature-Cide provides all-natural pest management solutions using botanical oils.</li><li>CEO highlights effective new formulation, Nature-Cide Pest Management X2 Plus.</li><li>AMCA meeting allows networking with industry leaders and professionals.</li><li>Med-X emphasizes commitment to safer, sustainable pest control solutions.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Med-X, Inc. (MXRX)</strong>: Med-X&#039;s focus on natural pest control aligns with growing industry trends.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>This falls under &#039;Corporate Developments&#039; as Med-X&#039;s participation at AMCA illustrates strategic promotional efforts to enhance brand recognition in a niche market.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Participation in AMCA could attract new clients and partnerships.</li><li>Effectiveness of Nature-Cide solutions could drive product demand.</li><li>Increased visibility may lead to higher sales in 2026.</li><li>Market sentiment could shift positively towards MEDH&#039;s growth potential.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Nature-Cide features botanical essential oils: clove, cottonseed, cedar, and cinnamon.</li><li>The AMCA Annual Meeting takes place March 23-27, 2026.</li><li>New formulation, Nature-Cide Pest Management X2 Plus, is OMRI-listed.</li><li>Med-X focuses on environmentally responsible pest control solutions.</li><li>AMCA meeting is a major event for pest management professionals.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>MEDH could experience positive momentum from increased visibility and potential partnerships at the AMCA event.</p>
  </section>
</section>


<p><i><strong>Nature-Cide to Highlight its Botanical Pest Control Solutions at Leading Mosquito Control Industry Event in Portland, Oregon</strong></i></p><p><strong id="dateline">LOS ANGELES, CA / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / March 23, 2026 / </strong>Med-X, Inc. ("Med-X" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/MXRX">MXRX</a>), a leading innovator in all-natural pest control solutions, today announced that its flagship Nature-Cide&#xAE; product line will be featured at the American Mosquito Control Association's (AMCA) 92nd Annual Meeting, taking place March 23-27, 2026, at the Oregon Convention Center in Portland, Oregon. Attendees are invited to visit Nature-Cide at Booth 214 to explore the Company's full portfolio of botanical pest management solutions.</p><p>The AMCA Annual Meeting is the premier educational and networking event for researchers, vector control professionals, public health officials, and industry leaders focused on mosquito control. The conference attracts hundreds of attendees annually and features scientific presentations, technical sessions, and an expansive exhibit hall showcasing the latest innovations in vector and pest management.</p><p>Nature-Cide's participation underscores Med-X's ongoing commitment to advancing safer, environmentally responsible alternatives within the professional vector control market. Nature-Cide products are formulated with a proprietary blend of botanical essential oils-including clove, cottonseed, cedar, and cinnamon-and have demonstrated effectiveness in independent third-party studies against a broad spectrum of insect. In addition to insect control, Nature-Cide products are also designed to repel rodents, reptiles, and certain bird species, without the harmful effects associated with traditional synthetic chemical pesticides.</p><p>Matthew Mills, CEO of Med-X, Inc. stated: "Our latest formulation, Nature-Cide Pest Management X2 Plus, which is OMRI listed, is proving very effective within the pest control industry. AMCA offers us the opportunity to continue making a difference in every aspect of pest control.</p><p>"Our management team, Board of Directors, as well as our shareholders are committed to continuing forging a path around the world to bring environmentally friendly solutions where they are needed the most."</p><p><strong>About Med-X, Inc.</strong><br/>Med-X, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/MXRX">MXRX</a>) is a leading innovator of biological pest control solutions serving both consumer and professional markets worldwide. Nature-Cide&#xAE;, the Company's flagship product line, provides a safer, all-natural alternative to conventional chemical pesticides and is formulated to kill or repel a wide range of pests. Med-X's comprehensive go-to-market strategy includes strategic partnerships, as well as an integrated presence across e-commerce, retail, and on-site services in key markets. For more information, please visit <a rel="nofollow" href="https://pr.report/jzqz">www.medx-rx.com</a>.</p><p><strong>Cautionary Note Regarding Forward-Looking Statements</strong><br/>This press release contains forward-looking statements within the meaning of applicable securities laws. These statements include, but are not limited to, statements regarding plans, objectives, strategies, future events, and expected performance. Words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," and similar expressions are intended to identify forward-looking statements. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including factors such as market conditions, competitive dynamics, regulatory developments, and other risks detailed in the Company's filings with the U.S. Securities and Exchange Commission (SEC). Investors are cautioned not to place undue reliance on forward-looking statements. Additional information can be found in the Company's SEC filings at <a rel="nofollow" href="https://pr.report/jzr0">www.sec.gov</a>.</p><p><strong>Investor Relations Contact</strong><br/>Lucas A. Zimmerman & Ian Scargill<br/>MZ Group - MZ North America<br/>(949) 259-4987<br/><a rel="nofollow" href="mailto:MXRX@mzgroup.us">MXRX@mzgroup.us</a><br/><a rel="nofollow" href="https://pr.report/jzr1">www.mzgroup.us</a></p><p><strong>SOURCE:</strong> Med-X, Inc.</p><br/><br/>View the original <a href='https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/med-x-to-showcase-nature-cide-at-amcas-92nd-annual-meeting-1150547'>press release</a> on ACCESS Newswire<br/><br/>
      <img src="https://app.accessnewswire.com/img.ashx?id=1150547" width="0" height="0"/>

Med-X, Inc. will showcase its Nature-Cide product line at the American Mosquito Control Association's Annual Meeting, emphasizing innovative pest control solutions. With a commitment to environmentally responsible alternatives, this event could bolster Med-X's market presence and lead to new partnerships.

Med-X to Showcase Nature-Cide at AMCA's 92nd Annual Meeting

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News